Enovis ENOV
NYSE ENOV
$18.60 -0.43 (-2.26%)
As of: Sep 10, 2026 · 12:40 PM EDT

Enovis (ENOV) Cash from Financing Activities (2010 - 2026)

Enovis' (ENOV) quarterly Cash from Financing Activities came in at -$50.6 million in Q3 2026, down 911.51% year-over-year from $6.2 million in Q3 2025, and down 294.31% quarter-over-quarter from $26.0 million in Q2 2026.

Analysis

Enovis (ENOV) Cash from Financing Activities (2010 - 2026) Analysis & Trends

Enovis (ENOV) has reported Cash from Financing Activities for 17 consecutive years, with -$50.6 million the latest figure, recorded in Q3 2026.

  • On a quarterly basis, Cash from Financing Activities fell 911.51% year-over-year to -$50.6 million in Q3 2026; TTM through Jul 2026 was -$134.4 million, a 461.25% decrease from a year earlier, with the FY2025 full-year figure at -$52.4 million, down 106.19% from the prior year.
  • Cash from Financing Activities was -$50.6 million for Q3 2026 at Enovis, down from $26.0 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $864.5 million in Q1 2024 and troughed at -$495.5 million in Q3 2022.
  • A 5-year average of $24.0 million and a median of $1.2 million in 2024 frame the typical range for Cash from Financing Activities.
  • Across the five-year window, Cash from Financing Activities jumped 3429.02% in 2024 and tumbled 24837.16% in 2025, its largest moves.
  • Over 5 years, Cash from Financing Activities stood at $41.6 million in 2022, then sank by 93.3% to $2.8 million in 2023, then sank by 819.97% to -$20.1 million in 2024, then tumbled by 263.12% to -$72.9 million in 2025, then jumped by 30.65% to -$50.6 million in 2026.
  • The last three Cash from Financing Activities figures came in at -$50.6 million (Q3 2026), $26.0 million (Q2 2026), and -$72.9 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 181.19 Bn 175.58 Bn 7.27 Bn -3.52 Bn
2 Intuitive Surgical 127.77 Bn 122.55 Bn 1.96 Bn -287.90 Mn
3 Medtronic 117.13 Bn 108.31 Bn 6.34 Bn -343.00 Mn
4 Stryker 104.67 Bn 101.20 Bn 4.50 Bn -95.00 Mn
5 Boston Scientific 64.48 Bn 63.94 Bn 3.85 Bn -410.00 Mn
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn -300,000.00
7 Alcon 33.06 Bn 31.61 Bn 1.68 Bn -510.00 Mn
8 Dexcom 32.37 Bn 30.43 Bn 830.00 Mn -607.30 Mn
9 Steris 20.76 Bn 20.28 Bn 684.20 Mn -213.50 Mn
10 Enovis 1.07 Bn 1.06 Bn 359.25 Mn -50.57 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 3, 2026 -50.57 Mn
Apr 3, 2026 26.02 Mn
Dec 31, 2025 -72.92 Mn
Oct 3, 2025 -36.91 Mn
Jul 4, 2025 6.23 Mn
Apr 4, 2025 51.19 Mn
Dec 31, 2024 -20.08 Mn
Sep 27, 2024 -148,000.00
Jun 28, 2024 2.51 Mn
Mar 29, 2024 864.54 Mn
Dec 31, 2023 2.79 Mn
Sep 29, 2023 -13.70 Mn
Jun 30, 2023 114.21 Mn
Mar 31, 2023 24.50 Mn
Dec 31, 2022 41.63 Mn
Sep 30, 2022 -456,000.00
Jul 1, 2022 -495.48 Mn
Apr 1, 2022 -10.82 Mn
Dec 31, 2021 473.07 Mn
Oct 1, 2021 40.15 Mn